Skip to main content
Future Journal of Pharmaceutical Sciences

Table 5 Results of method precision

From: Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR

S. no

Area of Rilpivirine

Area of Cabotegravir

1

2,542,689

1,344,264

2

2,553,130

1,371,927

3

2,505,117

1,323,328

4

2,577,854

1,384,891

5

2,591,109

1,355,421

6

2,514,689

1,391,485

Mean

2,547,431

1,361,886

SD

33,914.023

25,865.819

%RSD

1.33

1.90

Back to article page